Your browser doesn't support javascript.
loading
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation.
Shimomura, Yoshimitsu; Komukai, Sho; Kitamura, Tetsuhisa; Tachibana, Takayoshi; Kurosawa, Shuhei; Itonaga, Hidehiro; Tsukamoto, Shokichi; Doki, Noriko; Katayama, Yuta; Ito, Ayumu; Sawa, Masashi; Ueda, Yasunori; Nakamae, Hirohisa; Nawa, Yuichiro; Tanaka, Masatsugu; Arai, Yasuyuki; Ota, Shuichi; Kataoka, Keisuke; Nishida, Tetsuya; Kanda, Junya; Fukuda, Takahiro; Atsuta, Yoshiko; Ishiyama, Ken.
Afiliação
  • Shimomura Y; Department of Hematology, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Komukai S; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Kitamura T; Division of Biomedical Statistics, Department of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Tachibana T; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Kurosawa S; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Itonaga H; Department of Hematology, Yokohama Municipal Citizen's Hospital, Kawasaki-shi, Kanagawa, Japan.
  • Tsukamoto S; Transfusion and Cell Therapy Unit, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan.
  • Doki N; Department of Hematology, Chiba University Hospital, Chiba-shi, Chiba, Japan.
  • Katayama Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Ito A; Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
  • Sawa M; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ueda Y; Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo-shi, Aichi, Japan.
  • Nakamae H; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
  • Nawa Y; Department of Hematology, Osaka Metropolitan University, Graduate School of Medicine, Abeno-ku, Osaka, Japan.
  • Tanaka M; Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama-shi, Ehime, Japan.
  • Arai Y; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Ota S; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kataoka K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Nishida T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kanda J; Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Fukuda T; Department of Hematology, Japanese Red Cross Aichi Medical Center, Nagoya Daiichi Hospital, Nagoya-shi, Aichi, Japan.
  • Atsuta Y; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ishiyama K; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Br J Haematol ; 204(2): 612-622, 2024 02.
Article em En | MEDLINE | ID: mdl-37857379
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Limite: Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Limite: Humans / Male Idioma: En Revista: Br J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão